Apogee Enterprises (APOG)
(Delayed Data from NSDQ)
$40.40 USD
-1.59 (-3.79%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $40.37 -0.03 (-0.07%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
APOG 40.40 -1.59(-3.79%)
Will APOG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APOG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APOG
Wall Street Analysts Think Apogee Enterprises (APOG) Could Surge 25.44%: Read This Before Placing a Bet
Are Investors Undervaluing Apogee Enterprises (APOG) Right Now?
APOG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Apogee Enterprises (APOG) Could Rally 28.24%: Here's is How to Trade
Is Apogee Enterprises (APOG) Stock Undervalued Right Now?
Apogee Beats Q1 Earnings & Revenue Estimates, Hikes FY26 View
Other News for APOG
Dividend Champion, Contender, And Challenger Highlights: Week Of July 27
Reminder - Apogee Enterprises (APOG) Goes Ex-Dividend Soon
Dividend Champion, Contender, And Challenger Highlights: Week Of July 13
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Robinhood To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Tuesday